Cite
1H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ (DiRu-1)
MLA
Hedvika Primasová, et al. “1H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ (DiRu-1).” Metabolites, vol. 9, no. 7, July 2019, p. 146. EBSCOhost, https://doi.org/10.3390/metabo9070146.
APA
Hedvika Primasová, Lydia E. H. Paul, Gaëlle Diserens, Ester Primasová, Peter Vermathen, Martina Vermathen, & Julien Furrer. (2019). 1H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ (DiRu-1). Metabolites, 9(7), 146. https://doi.org/10.3390/metabo9070146
Chicago
Hedvika Primasová, Lydia E. H. Paul, Gaëlle Diserens, Ester Primasová, Peter Vermathen, Martina Vermathen, and Julien Furrer. 2019. “1H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ (DiRu-1).” Metabolites 9 (7): 146. doi:10.3390/metabo9070146.